
- March 2018 Central Nervous System
- Volume 84
- Issue 3
Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs
Continuing education activity featured in the March 2018 edition of Pharmacy Times.
This activity is supported by an educational grant from Sun Pharmaceutical Industries, Inc.
FACULTYJeffrey C. Lombardo, PharmD, BCOP
Research Assistant ProfessorCenter for Integrated Global Biomedical SciencesEmpire State Patient Safety Assurance NetworkSchool of Pharmacy and Pharmaceutical Sciences University at Buffalo State University of New York Buffalo, New York
MEDICAL WRITING AND EDITORIAL SUPPORTRachel L. Brown, PharmD, MPH
EDUCATIONAL OBJECTIVES
At the completion of this activity, the participant will be able to:
• Describe how exposure and contamination can lead to health risks to pharmacists and nurses who compound and administer hazardous drugs (HDs), such as chemotherapeutic agents
• Review the new USP chapter and be able to employ these measures to reduce or prevent unintentional exposure to HDs
• Discuss effective as well as protective and educational measures to minimize risks for those health care professionals who compound and administer HDs
TARGET AUDIENCE: Health-system pharmacists
ACTIVITY TYPE: Knowledge
RELEASE DATE: February 22, 2018
EXPIRATION DATE: May 22, 2019
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at
Articles in this issue
over 7 years ago
Social Interaction Can Improve Dementia Careover 7 years ago
High BMI Is Associated With Elevated Dementia Riskover 7 years ago
Concussions Are Linked to Heightened MS Risk in Teensover 7 years ago
CDC Report: Epilepsy Rates Increasing Among Adults and Childrenover 7 years ago
Parkinson Disease Progression Is Stalled by Intense Exerciseover 7 years ago
Pet Peeves (March 2018)over 7 years ago
Can You Read These Rxs? (March 2018)Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.